Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ABCB1 (P-glycoprotein/MDR1) and ABCG2 (BCRP) are major human ATP-binding cassette transporters that actively pump a wide variety of substrates—including many drugs—out of cells using energy from ATP hydrolysis. They are highly expressed in tissues involved in drug absorption and excretion (intestine, liver, kidney, blood-brain barrier) and are functionally associated with multidrug resistance, especially in tumor cells. Overexpression of either protein contributes to reduced intracellular drug levels and clinical resistance to chemotherapy. These proteins are also implicated in drug-drug interactions and variability in therapeutic response due to genetic polymorphisms and differential tissue expression.
Efflux of drugs out of cells, lowering intracellular concentrations and efficacy. Confer resistance to chemotherapy by reducing drug accumulation in tumor cells.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-binding cassette subfamily B member 1 (ABCB1) and ATP-binding cassette subfamily G member 2 (ABCG2) (ABCB1 and ABCG2).